The Procter & Gamble Company
—- Market cap
- $332.07B
- Debt
- +$34.14B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 91% equity / 9% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $332.07B · View financials
Snapshot Sep 9, 2026, 12:18 PM ET
FY 2025 ·
Decision snapshot: PG stock price vs PFE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PFE's multiple
Needs PFE P/E.
Implied fair value · at PG's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 91% equity / 9% debt
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
The Procter & Gamble Company · implied price per share
Bear
$81.64
Base
$98.63
Bull
$122.06
PFIZER INC · implied price per share
Bear
$10.17
Base
$12.82
Bull
$17.53
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
COLGATE PALMOLIVE CO
PG vs CL
KIMBERLY CLARK CORP
PG vs KMB
CHURCH & DWIGHT CO INC /DE/
PG vs CHD
CLOROX CO /DE/
PG vs CLX
Johnson & Johnson
PG vs JNJ
Merck & Co., Inc.
PG vs MRK
AbbVie Inc.
PG vs ABBV
BRISTOL MYERS SQUIBB CO
PG vs BMY
ELI LILLY & Co
PG vs LLY
AMGEN INC
PG vs AMGN
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe PG’s stronger growth, higher ROIC, and lower net leverage deserve a sustained premium versus PFE, then hold or accumulate on weakness; otherwise, the current price already embeds a valuation premium and the P/E signal points to limited near-term upside.
On the provided P/E-based valuation, PG’s implied price is $130.26 versus a current price of $145.79, suggesting 10.7% downside. The market is paying a premium for PG relative to PFE, and that premium appears tied to PG’s stronger revenue growth and higher profitability, though the stock is still trading above the low end of its historical band.
Supporting Metrics